FDA Import Refusal AEK-0397657-7/20002/1 — Caplin Point Lab Ltd
The FDA refused shipment AEK-0397657-7/20002/1 from Caplin Point Lab Ltd (India) on May 4, 2026. The refused product falls under Drugs and Biologics — AMPICILLIN (PENICILLIN, SYNTHETICALLY PRODUCED). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- May 4, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 56BDA05 AMPICILLIN (PENICILLIN, SYNTHETICALLY PRODUCED)
- Charges
- 75